Published in Blood Weekly, October 20th, 2005
"We have noted an unexpectedly high incidence of prostate cancer in our heart transplant recipients (HTR)," cardiologists in France explained.
S. Mohammadi and coauthors working at Hopital la Pitie-Salpetriere in Paris "conducted a retrospective review of patients after heart transplantation to investigate the prevalence, treatment, and outcome of prostate cancer diagnosed after systematic screening (study group)," compared with "case-matched HTR (control)."
"Among 702 recipients, 15 patients had elevated prostate-specific antigen (PSA) levels,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-10-20)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.